News Digest #202 – $12.3M for Evonetix and $10M for Engine Bio, SynBioBeta Early Bird ends today!

 

Hi all,

What does the global bioeconomy look like in 5, 10 or 20 years? What are the key cases of microbial-enabled manufacturing, how should they evolve in the coming years? Last year, fifty companies raised over $1.7 billion for the development of innovative synthetic biology technologies, check out our market map of them below. Join the discussion this October at SynBioBeta 2018 with code DIGEST by the end of the day to save $50.

Today, Engine Biosciences, a company whose team members include Tim Lu and Jim Collins from MIT, announced a $10 Million Series A financing to combine artificial intelligence and genomics to redesign drug discovery.

The next generation DNA synthesis market is heating up as Evonetix raised a $12.3 million (£9 million) Series A led by DCVC to develop technology that enables the parallel synthesis of DNA on silicon arrays. Paris-based DNA Script also announced an agreement with Dynamic Combinatorial Chemistry (DCC) to advance its enzymatic technology to synthesize long DNA fragments, towards entire genes and, eventually, chromosomes.


Hermann Hauser and Matt Ocko, Evonetix Investors.

Clean meat company Memphis Meats received investment from Tyson Foods’ venture capital arm. Tyson joins other top investors including Bill Gates and Richard Branson.

I hope you have a great week.

Regards,
John

Who’s Hiring?

PhD position with a focus on metabolic engineering and bioprocess development: Biosyntia, Denmark


Product Scientist: Opentrons, New York


Senior Scientist, Strain Engineering: Amyris, Emeryville, California


Senior Scientist, Enzyme Engineering: Amyris, Emeryville, California


Scientist, Cytochrome P450 Engineering: Amyris, Emeryville, California


Scientist, Strain Performance Optimization, PD&E: Amyris, Emeryville, California


Senior Director, Separations Process Development: Amyris, Emeryville, California


To feature your job here, please get in touch

News

Sphere Fluidics expands Cyto-Mine (Single Cell Analysis System) sales team and distribution in US, Europe and Asia


Responsible and Sustainable Synthetic Biology in Africa


Microbiome Company BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease


DEINOVE and Oléos, partners in the development of a new cosmetic active ingredient


How synthetic spider silk could change everything you wear


For postdocs looking to break into entrepreneurship, this MIT fellowship is helping light the way


Rainbow Seed Fund Changes Name to UK Innovation Science & Seed Fund


Engineered bacteria to detect gut inflammation (PLOS SynBio)


3 Promising Alternative Feeds for Aquaculture


BIO welcomes new Industrial & Environmental Section members


Copyright © %%current_year_YYYY%%, All rights reserved.

SynBioBeta
1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Add comment

Job opportunities

More